SCHEMBL6589774

SCHEMBL6589774

CCCCC(N)C(=O)OCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOD1 Q9Y239 4/20 0.50
DPP7 Q9UHL4 5/20 0.48
SLC15A1 P46059 1/20 0.48
SLC1A2 P43004 2/20 0.46
SLC1A1 P43005 2/20 0.46
SLC1A3 P43003 1/20 0.46
DPP4 P27487 4/20 0.44
DPP8 Q6V1X1 4/20 0.44
DPP9 Q86TI2 4/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
METAP1 P53582 1/20 0.43
ALOX15 P16050 1/20 0.41
TP53 P04637 1/20 0.41
CPB2 Q96IY4 1/20 0.41
GRIK1 P39086 1/20 0.40
GRIK2 Q13002 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7247852 1.00 NOD1 (0.50) NOD1DPP7SLC15A1SLC1A2SLC1A1
SCHEMBL27827672 1.00 NOD1 (0.50) NOD1DPP7SLC15A1SLC1A2SLC1A1
Hydrochloric Acid SCHEMBL6843156 0.98 NOD1 (0.49) NOD1DPP7SLC15A1SLC1A2SLC1A1
Hydrochloric Acid SCHEMBL5906900 0.98 NOD1 (0.49) NOD1DPP7SLC15A1SLC1A2SLC1A1
Acetic Acid SCHEMBL28857016 0.94 NOD1 (0.50) NOD1DPP7SLC15A1SLC1A2SLC1A1
SCHEMBL11296849 0.94 NOD1 (0.52) NOD1DPP7SLC15A1SLC1A2SLC1A1
SCHEMBL17821260 0.92 NOD1 (0.55) NOD1DPP7SLC1A2SLC1A1TP53
SCHEMBL11083554 0.92 NOD1 (0.55) NOD1DPP7SLC1A2SLC1A1TP53
Hydrochloric Acid SCHEMBL8203130 0.90 NOD1 (0.53) NOD1DPP7SLC1A2SLC1A1TP53
Hydrochloric Acid SCHEMBL2892786 0.90 NOD1 (0.53) NOD1DPP7SLC1A2SLC1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720203-A1 BARRIER COATINGS FOR PACKAGING MATERIALS Nabaco Inc. (US) 2026-04-08 EP claimed
WO-2024249334-A1 BARRIER COATINGS FOR PACKAGING MATERIALS NABACO INC. (US) 2024-12-05 WO claimed
CN-102343099-B Preparation method and application of folacin mediated tumor targeting adriamycin prodrugs FOURTH MILITARY MEDICAL UNIV 2012-11-28 CN claimed
EP-4720203-A1 BARRIER COATINGS FOR PACKAGING MATERIALS Nabaco Inc. (US) 2026-04-08 EP disclosed
WO-2024249334-A1 BARRIER COATINGS FOR PACKAGING MATERIALS NABACO INC. (US) 2024-12-05 WO disclosed
CN-118465112-A Method for detecting ethyl carbamate in coating of children product 新亚太检测技术服务(中山)有限公司 2024-08-09 CN disclosed
CN-117965329-A Pichia kudriavzevii, and culture method and application thereof 四川轻化工大学 2024-05-03 CN disclosed
US-20240067617-A1 BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS ALBIREO AB (SE) 2024-02-29 US disclosed
CN-117430539-A Preparation method of lactam and obtained product 中国石油化工股份有限公司 2024-01-23 CN disclosed
WO-2024008766-A1 BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS ALBIREO AB (SE) 2024-01-11 WO disclosed
CN-116615335-A Resin composition, flat molded body, multilayer body, molded article, and method for producing molded article 三菱瓦斯化学株式会社 2023-08-18 CN disclosed
US-6071912-A INHIBIT HUMAN FACTOR XA AND ARE THEREFORE USEFUL AS PHARMACOLOGICAL AGENTS FOR THE TREATMENT OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY; AMINO-, OXY- AND THIA-SUBSTITUTED TRIAZINES BERLEX LABORATORIES, INC. (US) 2000-06-06 US disclosed
EP-0888271-A4 BENZAMIDINE DERIVATIVES SUBSTITUTED BY AMINO ACID AND HYDROXY ACID DERIVATIVES AND THEIR USE AS ANTI-COAGULANTS BERLEX LAB (US) 2000-03-15 EP disclosed
US-5994375-A ANTICOAGULANTS BERLEX LABORATORIES, INC. (US) 1999-11-30 US disclosed
CN-1216545-A Farnesyl transferase inhibitors BIOMEASURE INC (US) 1999-05-12 CN disclosed
EP-0888271-A1 BENZAMIDINE DERIVATIVES SUBSTITUTED BY AMINO ACID AND HYDROXY ACID DERIVATIVES AND THEIR USE AS ANTI-COAGULANTS BERLEX LABORATORIES, INC. (US) 1999-01-07 EP disclosed
US-5777125-A Process for the preparation of tertiary carbinols containing an amino substituent GRUPPO LEPETIT SPA (IT) 1998-07-07 US disclosed
WO-1997029067-A1 BENZAMIDINE DERIVATIVES SUBSTITUTED BY AMINO ACID AND HYDROXY ACID DERIVATIVES AND THEIR USE AS ANTI-COAGULANTS BERLEX LABORATORIES, INC. (DE) 1997-08-14 WO disclosed
EP-0330875-B1 Process for the preparation of tertiary carbinols containing an aminic substituent LEPETIT SPA (IT) 1995-08-16 EP disclosed
EP-0330875-A2 Process for the preparation of tertiary carbinols containing an aminic substituent GRUPPO LEPETIT S.p.A. (IT) 1989-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240067617-A1 BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS SLC10A1, SLC10A2, ABCB11 NOD1 2287/4885DPP7 335/4885SLC15A1 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.